<!DOCTYPE html>
<html>
<head>
    <title>全文阅读--XML全文阅读--中国知网</title>
    <link rel="icon" href="/kxreader/favicon.ico" />
    <link rel="shortcut Icon" href="/kxreader/favicon.ico" />
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="文献 XML KBASE CNKI 中国知网" />
    <meta name="description" content="XML文献检索" />
    <link href="/kxreader/Content/css/detail?v=NOOK-mvTMnxl11s6oPYV0boPXN3iP4N7Rc-A56nk4KI1" rel="stylesheet"/>

    <script type="text/javascript">
        var APPPATH = '/kxreader';
    </script>
</head>

<body>
    
<script type="text/javascript" src="//login.cnki.net/TopLogin/api/loginapi/get?type=top&amp;localCSS=&amp;returnurl=%2f%2fkns.cnki.net%2fKXReader%2fDetail%3fTIMESTAMP%3d637141653714170000%26DBCODE%3dCJFD%26TABLEName%3dCJFDLAST2019%26FileName%3dXXGK201903024%26RESULT%3d1%26SIGN%3dUadQPgkmvgX2a0XO7GRxL7ahZnc%253d"></script>

<div id="headerBox" class="header">
    <div class="topbar">
        <div class="textalign">
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201903024&amp;align=md">
                <i class="icon-cen active" title="居中对齐"></i>
            </a>
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201903024&amp;align=lt">
                <i class="icon-left " title="左对齐"></i>
            </a>
        </div>
        <h6 class="free-tip"><i class="icon"></i>HTML阅读开放试用阶段，欢迎体验！</h6>
    </div>
</div>

    



<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201903024&amp;v=MDIzMTA1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbFZML05QVFhNWmJHNEg5ak1ySTlIWUlRS0RIODR2UjRUNmo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>

    <div class="main">

        

    <div class="sidebar-a">
        <!--sidebar start-->
        <div class="sidenav">
            <div class="arrow"><span></span></div>
            <!--sidebar_list start-->
            <dl class="sidenav-list">
                    <dt class="tit">目录结构</dt>
                            <dd class="guide">
                                    <p><a href="#34" data-title="&lt;b&gt;1 资料与方法&lt;/b&gt; "><b>1 资料与方法</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#35" data-title="1.1 一般资料">1.1 一般资料</a></li>
                                                <li><a href="#37" data-title="1.2 方法">1.2 方法</a></li>
                                                <li><a href="#39" data-title="1.3 评估指标及方法">1.3 评估指标及方法</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#45" data-title="&lt;b&gt;2 结 果&lt;/b&gt; "><b>2 结 果</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#46" data-title="2.1 两组患者总疗效对比">2.1 两组患者总疗效对比</a></li>
                                                <li><a href="#50" data-title="2.2 组间血液流变学改善效果比较">2.2 组间血液流变学改善效果比较</a></li>
                                                <li><a href="#54" data-title="2.3 组间LVEF、CRP水平改善及并发症比较">2.3 组间LVEF、CRP水平改善及并发症比较</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#58" data-title="&lt;b&gt;3 讨 论&lt;/b&gt; "><b>3 讨 论</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#" data-title="文内图表 ">文内图表</a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#48" data-title="&lt;b&gt;表&lt;/b&gt;1 &lt;b&gt;两组&lt;/b&gt;NIHSS&lt;b&gt;评分、颈动脉斑块面积及有效率比较&lt;/b&gt;&lt;mathml id=&quot;49&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mo stretchy=&quot;false&quot;&gt; (&lt;/mo&gt;&lt;mover accent=&quot;true&quot;&gt;&lt;mi&gt;x&lt;/mi&gt;&lt;mo&gt;&#175;&lt;/mo&gt;&lt;/mover&gt;&lt;mo&gt;&#177;&lt;/mo&gt;&lt;mi&gt;s&lt;/mi&gt;&lt;mo&gt;, &lt;/mo&gt;&lt;mtext&gt;n&lt;/mtext&gt;&lt;mo&gt;=&lt;/mo&gt;&lt;mn&gt;4&lt;/mn&gt;&lt;mn&gt;5&lt;/mn&gt;&lt;mo stretchy=&quot;false&quot;&gt;) &lt;/mo&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;"><b>表</b>1 <b>两组</b>NIHSS<b>评分、颈动脉斑块面积及有效率比较</b><mathml id="49"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo>, </mo><mtext>n</mtext><mo>=</mo><mn>4</mn><mn>5</mn><mo stretchy="false">) </mo></mrow></math></mathml></a></li>
                                                <li><a href="#52" data-title="&lt;b&gt;表&lt;/b&gt;2 &lt;b&gt;两组患者血液流变学指标比较&lt;/b&gt;&lt;mathml id=&quot;53&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mo stretchy=&quot;false&quot;&gt; (&lt;/mo&gt;&lt;mover accent=&quot;true&quot;&gt;&lt;mi&gt;x&lt;/mi&gt;&lt;mo&gt;&#175;&lt;/mo&gt;&lt;/mover&gt;&lt;mo&gt;&#177;&lt;/mo&gt;&lt;mi&gt;s&lt;/mi&gt;&lt;mo&gt;, &lt;/mo&gt;&lt;mtext&gt;n&lt;/mtext&gt;&lt;mo&gt;=&lt;/mo&gt;&lt;mn&gt;4&lt;/mn&gt;&lt;mn&gt;5&lt;/mn&gt;&lt;mo stretchy=&quot;false&quot;&gt;) &lt;/mo&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;"><b>表</b>2 <b>两组患者血液流变学指标比较</b><mathml id="53"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo>, </mo><mtext>n</mtext><mo>=</mo><mn>4</mn><mn>5</mn><mo stretchy="false">) </mo></mrow></math></mathml></a></li>
                                                <li><a href="#56" data-title="&lt;b&gt;表&lt;/b&gt;3 &lt;b&gt;两组&lt;/b&gt;C&lt;b&gt;反应蛋白、左心室射血分数水平及不良事件发生情况对比&lt;/b&gt;&lt;mathml id=&quot;57&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mo stretchy=&quot;false&quot;&gt; (&lt;/mo&gt;&lt;mover accent=&quot;true&quot;&gt;&lt;mi&gt;x&lt;/mi&gt;&lt;mo&gt;&#175;&lt;/mo&gt;&lt;/mover&gt;&lt;mo&gt;&#177;&lt;/mo&gt;&lt;mi&gt;s&lt;/mi&gt;&lt;mo&gt;, &lt;/mo&gt;&lt;mtext&gt;n&lt;/mtext&gt;&lt;mo&gt;=&lt;/mo&gt;&lt;mn&gt;4&lt;/mn&gt;&lt;mn&gt;5&lt;/mn&gt;&lt;mo stretchy=&quot;false&quot;&gt;) &lt;/mo&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;"><b>表</b>3 <b>两组</b>C<b>反应蛋白、左心室射血分数水平及不良事件发生情况对比</b><mathml id="57"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo>, </mo><mtext>n</mtext><mo>=</mo><mn>4</mn><mn>5</mn><mo stretchy="false">) </mo></mrow></math></mathml></a></li>
                                    </ul>
                            </dd>
                                    <dd class="guide">
                                        <h6>
                                            <p><a href="#a_bibliography">参考文献</a> </p>
                                        </h6>
                                    </dd>

            </dl>
        </div>
        <!--sidebar end-->
        &nbsp;
        <!--此处有一空格符 勿删-->
    </div>

                <div class="sidebar-b three-collumn" style="width:0;">
            <div class="refer" style="width: 0;">
                <div class="arrow off" title="参考文献"><span></span></div>
                <div class="js-scrollbox" >
                    
                    <div class="subbox active">
                        <h4>
                            <span class="tit">参考文献</span>
                            <a class="close" href="javascript:void(0)">x</a>
                        </h4>
                        <div class="side-scroller">
                            <ul class="refer-list">
                                <li id="78">


                                    <a id="bibliography_1" title="陈先震, 沈照立, 薛飞, 等.葛根素辅助脑蛋白水解物治疗缺血性脑血管病预后疗效分析J].中国医院药学杂志, 2013, 33 (1) :49-52." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGYZ201301017&amp;v=MDM2NTlNUHlyU2RMRzRIOUxNcm85RVk0UUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWTC8=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[1]</b>
                                        陈先震, 沈照立, 薛飞, 等.葛根素辅助脑蛋白水解物治疗缺血性脑血管病预后疗效分析J].中国医院药学杂志, 2013, 33 (1) :49-52.
                                    </a>
                                </li>
                                <li id="80">


                                    <a id="bibliography_2" title="宋爱霞, 纪蓉, 刘俊峰, 等.脑梗死患者血清生物标志物水平与颈动脉斑块的相关性研究[J].中国临床药理学杂志, 2016, 32 (3) :195-197, 201." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GLYZ201603001&amp;v=MDM4MzdML01JaUhTZExHNEg5Zk1ySTlGWllRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbFY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[2]</b>
                                        宋爱霞, 纪蓉, 刘俊峰, 等.脑梗死患者血清生物标志物水平与颈动脉斑块的相关性研究[J].中国临床药理学杂志, 2016, 32 (3) :195-197, 201.
                                    </a>
                                </li>
                                <li id="82">


                                    <a id="bibliography_3" title="谢坚, 张虹桥, 章成国, 等.瑞舒伐他汀与阿托伐他汀对急性脑梗死患者血脂、血清超敏C反应蛋白及颈动脉粥样硬化斑块作用的比较[J].临床神经病学杂志, 2015, 28 (1) :37-41." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=LCSJ201501019&amp;v=MTA3MDlqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWTC9NS1M3WVpMRzRIOVRNcm85RWJZUUtESDg0dlI0VDY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[3]</b>
                                        谢坚, 张虹桥, 章成国, 等.瑞舒伐他汀与阿托伐他汀对急性脑梗死患者血脂、血清超敏C反应蛋白及颈动脉粥样硬化斑块作用的比较[J].临床神经病学杂志, 2015, 28 (1) :37-41.
                                    </a>
                                </li>
                                <li id="84">


                                    <a id="bibliography_4" title="Chen R, Xiao A, Ma L, et al.Elevated hemoglobin is associated with cerebral infarction in Tibetan patients with primary hemorrhagic neurovascular diseases[J].Clin Neurol Neurosurg, 2017, 12 (16) :46-50." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJESDDB5D60B4D17B6B1858F9DD6B53E5778&amp;v=MjIzMjRJRnBtYUJ1SFlmT0dRbGZCckxVMDV0Qmh4TGk0d0t3PU5pZk9mY2ZNYk5TNHFZODNZSjhPQ3c0L3ZSY2I3emNMUVF1V3FtQXdlc2VSUXIyWENPTnZGU2lXV3I3Sg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[4]</b>
                                        Chen R, Xiao A, Ma L, et al.Elevated hemoglobin is associated with cerebral infarction in Tibetan patients with primary hemorrhagic neurovascular diseases[J].Clin Neurol Neurosurg, 2017, 12 (16) :46-50.
                                    </a>
                                </li>
                                <li id="86">


                                    <a id="bibliography_5" title="钟楚锋, 黎丽娴, 周环, 等.醒脑静联合脑蛋白水解物对脑卒中患者血管内皮依赖性舒张功能的影响[J].广东医学, 2013, 34 (17) :2713-2714." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GAYX201317049&amp;v=MDU5NzA1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbFZML01JaXpTZHJHNEg5TE5xSTlCYllRS0RIODR2UjRUNmo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[5]</b>
                                        钟楚锋, 黎丽娴, 周环, 等.醒脑静联合脑蛋白水解物对脑卒中患者血管内皮依赖性舒张功能的影响[J].广东医学, 2013, 34 (17) :2713-2714.
                                    </a>
                                </li>
                                <li id="88">


                                    <a id="bibliography_6" title="李强, 华梅, 李鸣, 等.强化他汀治疗对脑梗死患者血清HMGB1 IL-17A和S-100A12水平的影响[J].中风与神经疾病杂志, 2016, 33 (2) :109-112." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZFSJ201602003&amp;v=MzA4NDVMRzRIOWZNclk5Rlo0UUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWTC9NUHl2WVo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[6]</b>
                                        李强, 华梅, 李鸣, 等.强化他汀治疗对脑梗死患者血清HMGB1 IL-17A和S-100A12水平的影响[J].中风与神经疾病杂志, 2016, 33 (2) :109-112.
                                    </a>
                                </li>
                                <li id="90">


                                    <a id="bibliography_7" title="Yokokawa R, Akino H, Ito H, et al.Nerve growth factor release from the urothelium increases via activation of bladder C-fiber in rats with cerebral infarction[J].Neurourol Urodyn, 2017, 36 (6) :1448-1455." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWD&amp;filename=SJWD5CF0A631DB8BB6B403753D295D23FDAE&amp;v=MTY4NTg0L3ZSSVQ2VGg0U3d2Z3BSZEJlN0hpTWN2cUNPTnZGU2lXV3I3SklGcG1hQnVIWWZPR1FsZkJyTFUwNXRCaHhMaTR3S3c9TmlmY2FyYkxhTkc5cVl4RUVKa0hmZw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[7]</b>
                                        Yokokawa R, Akino H, Ito H, et al.Nerve growth factor release from the urothelium increases via activation of bladder C-fiber in rats with cerebral infarction[J].Neurourol Urodyn, 2017, 36 (6) :1448-1455.
                                    </a>
                                </li>
                                <li id="92">


                                    <a id="bibliography_8" title="张成刚, 孙中武.阿托伐他汀钙联合氯吡格雷预防老年短暂性脑缺血发作患者脑梗死的效果及对血脂、血小板的影响[J].中国老年学杂志, 2016, 36 (19) :4759-4760." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZLXZ201619039&amp;v=MjczNTBabUZ5amxWTC9NUHlIVGRMRzRIOWZOcG85R2JZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnU=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[8]</b>
                                        张成刚, 孙中武.阿托伐他汀钙联合氯吡格雷预防老年短暂性脑缺血发作患者脑梗死的效果及对血脂、血小板的影响[J].中国老年学杂志, 2016, 36 (19) :4759-4760.
                                    </a>
                                </li>
                                <li id="94">


                                    <a id="bibliography_9" title="张慧敏.C反应蛋白水平与脑梗死患者颈动脉粥样硬化的相关性研究[J].现代预防医学, 2013, 40 (6) :1011-1012, 1016." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XDYF201306006&amp;v=MTU3NzBabUZ5amxWTC9NUFNuU2FMRzRIOUxNcVk5RllvUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnU=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[9]</b>
                                        张慧敏.C反应蛋白水平与脑梗死患者颈动脉粥样硬化的相关性研究[J].现代预防医学, 2013, 40 (6) :1011-1012, 1016.
                                    </a>
                                </li>
                                <li id="96">


                                    <a id="bibliography_10" title="王映林, 李青叶.辛伐他汀对脑梗死患者神经功能及预后的影响[J].中国药房, 2017, 28 (26) :3708-3710." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGYA201726031&amp;v=MDEzNjRSN3FmWnVabUZ5amxWTC9NUHlyU2I3RzRIOWJPcVk5R1pZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1U=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[10]</b>
                                        王映林, 李青叶.辛伐他汀对脑梗死患者神经功能及预后的影响[J].中国药房, 2017, 28 (26) :3708-3710.
                                    </a>
                                </li>
                                <li id="98">


                                    <a id="bibliography_11" title="岳蕴华, 白旭东, 张小宁, 等.普罗布考联合阿托伐他汀对脑梗死患者血清hsCRP、ox-LDL、MMP-9水平及颈动脉斑块的影响[J].中国神经精神疾病杂志, 2014, 40 (11) :641-645." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZSJJ201411001&amp;v=MTI5MzJPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWTC9NUHo3QlpMRzRIOVhOcm85RlpZUUtESDg0dlI0VDZqNTQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[11]</b>
                                        岳蕴华, 白旭东, 张小宁, 等.普罗布考联合阿托伐他汀对脑梗死患者血清hsCRP、ox-LDL、MMP-9水平及颈动脉斑块的影响[J].中国神经精神疾病杂志, 2014, 40 (11) :641-645.
                                    </a>
                                </li>
                                <li id="100">


                                    <a id="bibliography_12" title="李小华, 黄康.瑞舒伐他汀与辛伐他汀治疗老年冠心病伴高胆固醇血症的临床对比[J].中国老年学杂志, 2015, 35 (22) :6427-6428." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZLXZ201522052&amp;v=MDQyMzh0R0ZyQ1VSN3FmWnVabUZ5amxWTC9NUHlIVGRMRzRIOVRPclk5QVpvUUtESDg0dlI0VDZqNTRPM3pxcUI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[12]</b>
                                        李小华, 黄康.瑞舒伐他汀与辛伐他汀治疗老年冠心病伴高胆固醇血症的临床对比[J].中国老年学杂志, 2015, 35 (22) :6427-6428.
                                    </a>
                                </li>
                                <li id="102">


                                    <a id="bibliography_13" title="Xu X, Li C, Wan T, et al.Risk Factors for Hemorrhagic Transformation After Intravenous Thrombolysis in Acute Cerebral Infarction:A Retrospective Single-Center Study[J].World Neurosurg, 2017, 101:155-160." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJESF9879F87B77AF0D2074EE26221B2C134&amp;v=MTE2NjhyTFUwNXRCaHhMaTR3S3c9TmlmT2ZjV3hGdGJGMllkQ0Z1d0lmUW81dXhRVDdUc0lQWDNrcmhBMEM3RG5STG1iQ09OdkZTaVdXcjdKSUZwbWFCdUhZZk9HUWxmQg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[13]</b>
                                        Xu X, Li C, Wan T, et al.Risk Factors for Hemorrhagic Transformation After Intravenous Thrombolysis in Acute Cerebral Infarction:A Retrospective Single-Center Study[J].World Neurosurg, 2017, 101:155-160.
                                    </a>
                                </li>
                                <li id="104">


                                    <a id="bibliography_14" title="张安兴.不同剂量阿托伐他汀钙预防颈动脉粥样硬化患者脑梗塞的作用[J].心血管康复医学杂志, 2011, 20 (3) :256-257." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201103021&amp;v=MTQ2NjBESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWTC9NUFRYTVpiRzRIOURNckk5SFpZUUs=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[14]</b>
                                        张安兴.不同剂量阿托伐他汀钙预防颈动脉粥样硬化患者脑梗塞的作用[J].心血管康复医学杂志, 2011, 20 (3) :256-257.
                                    </a>
                                </li>
                            </ul>
                            <div style='display: none;' class="zqscroller" >
                                <h4 class="">附加材料</h4>
                                <ul></ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            &nbsp;
            <!--此处有一空格符 勿删-->
        </div>

        
    <div class="content">



        <!--tips start-->
                            <div class="tips">
                    <a href="http://navi.cnki.net/KNavi/JournalDetail?pcode=CJFD&amp;pykm=XXGK" target="_blank">心血管康复医学杂志</a>
                2019,28(03),352-356 DOI:10.3969/j.issn.1008-0074.2019.03.23            </div>
        <!--tips end-->
            <div class="top-title">
                <h1 class="title">
                    <span class="vm"><b>脑蛋白水解物和辛伐他汀对脑梗死患者颈动脉粥样斑块的疗效及对</b>LVEF<b>和</b>CRP<b>水平的影响</b></span>
                                    </h1>

            </div>
                        <h2>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E6%9D%A8%E6%AC%A2&amp;code=21869099&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">杨欢</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%BC%A0%E7%8F%8A%E7%8F%8A&amp;code=38450101&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">张珊珊</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E4%BD%99%E8%8A%BE%E6%88%90&amp;code=20728995&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">余芾成</a>
                </h2>
                    <h2>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E5%AD%9D%E6%84%9F%E5%B8%82%E4%B8%AD%E5%BF%83%E5%8C%BB%E9%99%A2%E7%A5%9E%E7%BB%8F%E5%86%85%E7%A7%91&amp;code=0096027&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">孝感市中心医院神经内科</a>
            </h2>

        
<div class="link">
    <a id="aexport" class="icon icon-output"  onclick="" href="javascript:void(0);"><i></i>导出/参考文献</a>
    
    <span class="shareBoard" onmouseover="$('#sharedet').show();$('#this').addClass('shareBoardCUR')" onmouseout="$('#sharedet').hide();$('#this').removeClass('shareBoardCUR')">
        <a class="icon icon-share" href="#"><i></i>分享<em></em></a>
        <ul class="shareHide" id="sharedet" style="display: none;">
            <li><a title="复制链接" class="copy" onclick="" href="#"><i></i>复制链接</a></li>
            <li><a title="分享到新浪微博" class="xl" onclick="" href="javascript:common.ShareAction('xl');"><i></i>新浪微博</a></li>
            <li>
                <a title="分享到微信" class="wx" onclick="" href="#"><i></i>微信扫一扫</a>
                <div class="qrcode"><img src='' alt='' /></div>
            </li>
        </ul>

    </span>
    
    <a id="RefTrack" title="创建引文跟踪" class="icon icon-track" onclick="" href="javascript:void(0);"> <i></i>创建引文跟踪 </a>
    <a id="ashoucang" title="收藏" class="icon icon-favor" onclick="" href="javascript:void(0);"><i></i>收藏</a>
    <a class="icon icon-print" onclick="window.print();" href="javascript:void(0);"><i></i>打印</a>
    
    <!--版本切换 end-->
</div>
                            <div class="data" id="a_abstract">
                <span class="keys">摘<span style="font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;</span>要：</span>
                <p><b>目的</b>:探讨辛伐他汀、脑蛋白水解物治疗脑梗死合并颈动脉粥样斑块患者的临床价值, 及对LVEF和CRP水平的影响。<b>方法</b>:选择2016年3月～2017年5月于我院治疗的90例脑梗死合并颈动脉粥样斑块患者, 随机均分为常规治疗组和联合治疗组 (常规治疗基础上接受辛伐他汀+脑蛋白水解物治疗) , 治疗4周。比较两组临床疗效, 治疗前后美国国立卫生研究院卒中评分量表 (NIHSS) 得分、颈动脉斑块相关指标、血液流变学指标、左室射血分数 (LVEF) 、血清C反应蛋白 (CRP) 及不良事件发生情况。<b>结果</b>:治疗后, 与常规治疗组比较, 联合治疗组NIHSS评分[ (15.56±6.33) 分比 (12.14±3.18) 分]、颈动脉斑块面积[ (1.54±0.32) cm<sup>2</sup>比 (1.34±0.30) cm<sup>2</sup>]、内膜中层厚度[ (1.37±0.08) mm比 (1.15±0.04) mm]均明显下降 (<i>P</i>均&lt;0.01) , 治疗总有效率 (80.00%比95.56%) 则显著升高 (<i>P</i>=0.024) ;血液流变学指标[红细胞压积 (44.24±3.24) %比 (37.72±2.41) %, 血小板聚集率 (45.62±15.95) %比 (38.10±2.52) %, 纤维蛋白原 (4.06±1.43) g/L比3.18±1.15) g/L, 全血粘度 (2.66±0.77) mPa·s比 (1.55±0.25) mPa·s, 血浆粘度 (1.45±0.11) mPa·s比 (1.21±0.16) mPa·s]、血清CRP[ (4.36±1.03) mg/L比 (1.70±0.20) mg/L]显著降低, 而LVEF[ (49.30±3.74) %比 (56.67±4.37) %]则显著增加 (<i>P</i>均&lt;0.01) ;联合治疗组患者的心脑血管事件发生率显著降低 (17.18%比4.44%, <i>P</i>=0.004) 。<b>结论</b>:在常规治疗基础上给予脑梗死伴颈动脉粥样斑块患者辛伐他汀、脑蛋白水解物治疗, 可获得更理想的总体疗效, 并降低并发症发生率。</p>
            </div>
                    <div class="data" id="a_keywords">
                <span class="keys">关键词：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E8%84%91%E6%A2%97%E6%AD%BB&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">脑梗死;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E8%9B%8B%E7%99%BD%E6%B0%B4%E8%A7%A3%E4%BA%A7%E7%89%A9&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">蛋白水解产物;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E8%BE%9B%E4%BC%90%E4%BB%96%E6%B1%80&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">辛伐他汀;</a>
                </p>
            </div>
        
        <!--brief start-->
        
            <div class="brief">
                    <p>
                                            </p>
                                    <p><b>收稿日期：</b>2018-01-09</p>

            </div>
                    <h1>Therapeutic effect of brain protein hydrolysate and simvastatin on carotid atherosclerotic plaques in CI patients and its influence on LVEF and CRP level</h1>
                    <h2>
                    <span>YANG Huan</span>
                    <span>ZHANG Shan-shan</span>
                    <span>YU Fei-cheng</span>
            </h2>
                    <h2>
                    <span>Department of Neurology, Central Hospital of Xiaogan City</span>
            </h2>
                            <div class="data" id="a_abstractEN">
                <span class="keys">Abstract：</span>
                <p><b>Objective</b>:To explore clinical value of brain protein hydrolysate (BPH) and simvastatin in treatment of patients with cerebral infarction (CI) complicated carotid atherosclerotic plaques (CAP) .<b>Methods</b>:A total of 90 CI + CAP patients treated in our hospital from Mar 2016 to May 2017 were selected, randomly and equally divided into routine treatment group and combined treatment group (received simvastatin + BPH based on routine treatment) , both groups were treated for four weeks. Therapeutic effect, United States National Institutes of Health Stroke Score (NIHSS) , CAP-related indexes, hemorheology indexes, LVEF and CRP before and after treatment and incidence of adverse events were compared between two groups.<b>Results</b>:Compared with routine treatment group after treatment, there were significant reductions in NIHSS score [ (15.56±6.33) scores vs. (12.14±3.18) scores], CAP size[ (1.54±0.32) cm<sup>2</sup> vs. (1.34±0.30) cm<sup>2</sup> ], intima-media thickness[ (1.37±0.08) mm vs. (1.15±0.04) mm] (<i>P</i>&lt;0.01 all) , and significant rise in total effective rate (80.00% vs. 95.56%, <i>P</i>=0.024) in combined treatment group; there were significant reductions in hematocrit [ (44.24±3.24) % vs. (37.72±2.41) %], platelet aggregation rate [ (45.62±15.95) % vs. (38.10±2.52) %], fibrinogen [ (4.06±1.43) g/L vs. (3.18±1.15) g/L], whole blood viscosity [ (2.66±0.77) mPa·s vs. (1.55±0.25) mPa·s], plasma viscosity [ (1.45±0.11) mPa·s vs. (1.21±0.16) mPa·s]and serum CRP level [ (4.36±1.03) mg/L vs. (1.70±0.20) mg/L], and significant rise in LVEF [ (49.30±3.74) % vs. (56.67±4.37) %]in combined treatment group, <i>P</i>&lt;0.01 all. Incidence rate of cardio-and cerebrovascular events in combined treatment group was significantly lower than that of routine treatment group (4.44% vs. 17.18%, <i>P</i>=0.004) .<b>Conclusion</b>:Simvastatin combined BPH based on routine treatment can achieve better total therapeutic effect and reduce incidence rate of complications in CI + CAP patients.</p>
            </div>
                    <div class="data" id="a_keywordsEN">
                <span class="keys">Keyword：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Brain%20infarction&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Brain infarction;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Protein%20hydrolysates&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Protein hydrolysates;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Simvastatin&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Simvastatin;</a>
                </p>
            </div>
                    <div class="brief">
                
                    <p>
                                            </p>
                                    <p><b>Received：</b> 2018-01-09</p>
                            </div>


        <!--brief start-->
                        <div class="p1">
                    <p id="33">颈动脉粥样斑块是引发缺血性脑血管病的一个重要危险因素, 缺血性脑血管病的治疗、预防均须高度重视斑块的治疗<citation id="106" type="reference"><link href="78" rel="bibliography" /><sup>[<a class="sup">1</a>]</sup></citation>。目前主要通过常规对症处理方式治疗脑梗死伴颈动脉粥样斑块患者, 但总体治疗效果欠佳, 因此须进一步加强对该类患者更有效治疗方式进行深入研究。本研究探讨辛伐他汀、脑蛋白水解物应用于脑梗死伴颈动脉粥样斑块患者治疗的临床价值, 现做如下报告。</p>
                </div>
                <h3 id="34" name="34" class="anchor-tag"><b>1 资料与方法</b></h3>
                <h4 class="anchor-tag" id="35" name="35">1.1 一般资料</h4>
                <div class="p1">
                    <p id="36">从本院2016年3月～2017年5月收治脑梗死伴颈动脉粥样斑块患者中选择90例作为研究对象。按随机数字表法患者均分为两组。联合治疗组45例, 男26例, 女19例, 年龄40～77 (54.5±3.6) 岁, 病程1～10 (4.4±0.5) 年。常规治疗组45例, 男27例, 女18例;年龄41～76 (53.8±3.8) 岁, 病程1～9 (4.3±0.2) 年。两组一般资料比较组无显著差异 (<i>P</i>均&gt;0.05) 。具有可比性。纳入标准:①符合脑梗死临床诊断标准<citation id="107" type="reference"><link href="80" rel="bibliography" /><sup>[<a class="sup">2</a>]</sup></citation>, 且经CT或MRI检查得到确诊;②患者本人或家属签署知情同意书;③超声检查明确存在颈动脉粥样斑块:颈动脉内中膜厚度≥1.5mm, 同时内膜增厚朝向血管腔内凸出;④首次发病, 且在发病后72h内诊治。排除标准:①对研究所用药物过敏;②伴有肝肾功能异常、恶性肿瘤、血液疾病、心肌梗死;③近期受过严重外伤或接受手术治疗;④伴有慢性炎症、自身免疫系统疾病。</p>
                </div>
                <h4 class="anchor-tag" id="37" name="37">1.2 方法</h4>
                <div class="p1">
                    <p id="38">给予常规治疗组患者常规治疗, 内容为抗血小板聚集、溶栓、扩容、降纤、血糖及血压调控、脑代谢改善等。同时以患者病情变化为根据, 给予甘露醇、川芎嗪等治疗, 并给予尼莫地平、阿司匹林等预防并发症。在此治疗基础上, 再给予联合治疗组患者辛伐他汀 (厦门福满药业有限公司生产, 商品名:仁和, 国药准字:H20093998) +脑蛋白水解物 (奥地利EVER Neuro Pharma GmbH生产, 商品名:施普善, 注册证号:H20100440) 治疗。患者于晚饭后口服辛伐他汀胶囊10mg/次, 1次/d。将120mg脑蛋白水解物注射液溶入250mg生理盐水中, 静脉滴<citation id="108" type="reference"><link href="78" rel="bibliography" />注1</citation>次/d, 1个治疗疗程为2周。两组患者均持续接受治疗2个疗程。</p>
                </div>
                <h4 class="anchor-tag" id="39" name="39">1.3 评估指标及方法</h4>
                <div class="p1">
                    <p id="40">治疗后给予两组患者至少6个月随访, 了解患者治疗后病情恢复情况, 并进行效果评估。</p>
                </div>
                <h4 class="anchor-tag" id="41" name="41">1.3.1 相关指标水平变化评估:</h4>
                <div class="p1">
                    <p id="42">分别在治疗前、后实施相关指标检测。①检测血液流变学指标水平, 指标为血小板凝聚率 (PA) 、红细胞压积 (HCT) 、血浆黏度 (BV) 、全血黏度 (WBV) 、纤维蛋白原 (FBG) 。观察患者颈动脉斑块面积、内膜中层厚度变化;②测定血清C反应蛋白 (CRP) 水平、评估左心室射血分数 (LVEF) 变化。</p>
                </div>
                <h4 class="anchor-tag" id="43" name="43">1.3.2 安全性及总疗效评估<citation id="110" type="reference"><link href="82" rel="bibliography" /><sup>[<a class="sup">3</a>]</sup></citation>:</h4>
                <div class="p1">
                    <p id="44">观察患者并发症发生情况。治疗前、后评估患者神经功能缺损评分 (NIHSS) <citation id="109" type="reference"><link href="84" rel="bibliography" /><sup>[<a class="sup">4</a>]</sup></citation>、颈动脉斑块面积。显效:体征、症状基本消失, NIHSS评分减少、梗死体积缩小程度均≥50%;有效:体征、症状均有显著好转, 梗死体积缩小、NIHSS评分减少程度分别为20%～50%、18%～50%;无效:体征、症状均无好转, NIHSS评分减少、梗死体积缩小程度分别低于20%、18%。有效率、显效率之和为总有效率。</p>
                </div>
                <h3 id="45" name="45" class="anchor-tag"><b>2 结 果</b></h3>
                <h4 class="anchor-tag" id="46" name="46">2.1 两组患者总疗效对比</h4>
                <div class="p1">
                    <p id="47">联合治疗组治疗后NIHSS评分、颈动脉斑块面积均显著低于常规治疗组, 总有效率显著高于常规治疗组 (<i>P</i>&lt;0.05) , 见表1。</p>
                </div>
                <div class="area_img" id="48">
                    <p class="img_tit"><b>表</b>1 <b>两组</b>NIHSS<b>评分、颈动脉斑块面积及有效率比较</b><mathml id="49"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo>, </mo><mtext>n</mtext><mo>=</mo><mn>4</mn><mn>5</mn><mo stretchy="false">) </mo></mrow></math></mathml> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="48" border="1"><tr><td>组别</td><td>时间</td><td>NIHSS评分<br /> (分) </td><td>颈动脉斑块面积<br /> (cm<sup>2</sup>) </td><td>颈动脉内膜中层<br />厚度 (mm) </td><td>显效<br /><i>n</i> (%) </td><td>有效<br /><i>n</i> (%) </td><td>无效<br /><i>n</i> (%) </td><td>总有效率<br /><i>n</i> (%) </td></tr><tr><td><br />常规治疗组</td><td>治疗前</td><td>23.59±6.46</td><td>1.77±0.42</td><td>1.43±0.16</td><td>16 (35.56) </td><td>20 (44.44) </td><td>9 (20.00) </td><td>36 (80.00) </td></tr><tr><td><br /></td><td>治疗后</td><td>15.56±6.33<sup>**</sup></td><td>1.54±0.32<sup>**</sup></td><td>1.37±0.08<sup>*</sup></td><td></td><td></td><td></td><td></td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td></td><td>5.955/0.001</td><td>2.922/0.005</td><td>2.250/0.015</td><td></td><td></td><td></td><td></td></tr><tr><td><br />联合治疗组</td><td>治疗前</td><td>24.52±6.36</td><td>1.78±0.32</td><td>1.44±0.13</td><td>20 (44.44) </td><td>23 (51.11) </td><td>2 (4.44) </td><td>43 (95.56) </td></tr><tr><td><br /></td><td>治疗后</td><td>12.14±3.18<sup>**△△</sup></td><td>1.34±0.30<sup>**△△</sup></td><td>1.15±0.04<sup>**△△</sup></td><td></td><td></td><td></td><td></td></tr><tr><td><br /><i>t</i> (<i>χ</i><sup>2</sup>) /<i>P</i></td><td></td><td>11.679/0.001</td><td>6.729/0.001</td><td>14.302/0.001</td><td>5.074/0.024</td><td></td><td></td><td></td></tr><tr><td><br />组间治疗前<i>t</i>/<i>P</i></td><td></td><td>0.688/0.424</td><td>0.127/0.983</td><td>0.325/0.781</td><td></td><td></td><td></td><td></td></tr><tr><td><br />组间治疗后<i>t</i>/<i>P</i></td><td></td><td>3.238/0.002</td><td>3.058/0.002</td><td>16.500/0.001</td><td></td><td></td><td></td><td></td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:与治疗前比较*<i>P</i>&lt;0.05, **<i>P</i>&lt;0.01;与常规治疗组比较△<i>P</i>&lt;0.05, △△<i>P</i>&lt;0.01。下表同。</p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="50" name="50">2.2 组间血液流变学改善效果比较</h4>
                <div class="p1">
                    <p id="51">两组治疗前HCT、FBG、PA、PV、WBV各项指标比较均无显著差异 (<i>P</i>&gt;0.05) 。治疗后, 联合治疗组各项指标均低于常规治疗组 (<i>P</i>&lt;0.05) , 见表2。</p>
                </div>
                <div class="area_img" id="52">
                    <p class="img_tit"><b>表</b>2 <b>两组患者血液流变学指标比较</b><mathml id="53"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo>, </mo><mtext>n</mtext><mo>=</mo><mn>4</mn><mn>5</mn><mo stretchy="false">) </mo></mrow></math></mathml> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="52" border="1"><tr><td><br />组别</td><td>时间</td><td>红细胞压积<br /> (%) </td><td>血小板凝聚率<br /> (%) </td><td>纤维蛋白原<br /> (g/L) </td><td>全血黏度<br /> (mPa·s) </td><td>血浆黏度<br /> (mPa·s) </td></tr><tr><td><br />常规治疗组</td><td>治疗前</td><td>50.13±4.85</td><td>57.95±10.32</td><td>4.82±1.74</td><td>5.67±0.52</td><td>1.64±0.46</td></tr><tr><td><br /></td><td>治疗后</td><td>44.24±3.24<sup>**</sup></td><td>45.62±15.95<sup>**</sup></td><td>4.06±1.43<sup>*</sup></td><td>2.66±0.77<sup>**</sup></td><td>1.45±0.11<sup>**</sup></td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td></td><td>6.774/0.001</td><td>4.353/0.001</td><td>2.263/0.024</td><td>21.731/0.001</td><td>2.694/0.008</td></tr><tr><td><br />联合治疗组</td><td>治疗前</td><td>49.85±4.92</td><td>57.89±10.28</td><td>4.91±1.58</td><td>5.63± 0.57</td><td>1.63±0.36</td></tr><tr><td><br /></td><td>治疗后</td><td>37.72±2.41<sup>**△△</sup></td><td>38.10±2.52<sup>**△△</sup></td><td>3.18±1.15<sup>**△△</sup></td><td>1.55±0.25<sup>**△△</sup></td><td>1.21±0.16<sup>**△△</sup></td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td></td><td>14.852/0.001</td><td>12.542/0.001</td><td>5.938/0.001</td><td>43.973/0.001</td><td>7.151/0.001</td></tr><tr><td><br />组间治疗前<i>t</i>/<i>P</i></td><td></td><td>0.271/0.821</td><td>0.027/0.908</td><td>0.256/0.856</td><td>0.347/0.762</td><td>0.114/0.894</td></tr><tr><td><br />组间治疗后<i>t</i>/<i>P</i></td><td></td><td>10.831/0.001</td><td>3.123/0.002</td><td>3.216/0.002</td><td>9.197/0.001</td><td>8.291/0.001</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="54" name="54">2.3 组间LVEF、CRP水平改善及并发症比较</h4>
                <div class="p1">
                    <p id="55">联合治疗组治疗后LVEF高于常规治疗组, CRP水平低于常规治疗组 (<i>P</i>&lt;0.05) , 心脑血管事件发生率低于常规治疗组 (<i>P</i>&lt;0.05) , 见表3。</p>
                </div>
                <div class="area_img" id="56">
                    <p class="img_tit"><b>表</b>3 <b>两组</b>C<b>反应蛋白、左心室射血分数水平及不良事件发生情况对比</b><mathml id="57"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo>, </mo><mtext>n</mtext><mo>=</mo><mn>4</mn><mn>5</mn><mo stretchy="false">) </mo></mrow></math></mathml> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="56" border="1"><tr><td rowspan="2"><br />组别</td><td colspan="3"><br />左心室射血分数 (%) </td><td colspan="3">C反应蛋白 (mg/L) </td><td colspan="3">并发症<i>n</i> (%) </td></tr><tr><td>治疗前</td><td>治疗后</td><td><i>t</i>/<i>P</i></td><td>治疗前</td><td>治疗后</td><td><i>t</i>/<i>P</i></td><td>急性冠脉<br />综合症</td><td>缺血性<br />脑卒中</td><td>总发生率</td></tr><tr><td>常规治疗组</td><td>44.23±2.52</td><td>49.30±3.74<sup>**</sup></td><td>7.541/0.001</td><td>5.77±1.13</td><td>4.36±1.03<sup>**</sup></td><td>6.186/0.001</td><td>3 (6.67) </td><td>5 (11.11) </td><td>8 (17.18) </td></tr><tr><td><br />联合治疗组</td><td>45.18±2.41</td><td>56.67±4.37<sup>**△△</sup></td><td>15.444/0.001</td><td>5.79±1.09</td><td>1.70±0.20<sup>**△△</sup></td><td>24.758/0.001</td><td>1 (2.22) </td><td>1 (2.22) </td><td>2 (4.44) </td></tr><tr><td><br /><i>t</i> (<i>χ</i><sup>2</sup>) /<i>P</i></td><td>1.827/0.071</td><td>8.595/0.001</td><td></td><td>0.085/0.921</td><td>17.006/0.001</td><td></td><td></td><td></td><td>4.050/0.044</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <h3 id="58" name="58" class="anchor-tag"><b>3 讨 论</b></h3>
                <div class="p1">
                    <p id="59">脑梗死为临床治疗中最常见的脑卒中类型之一, 其还可称为缺血性脑卒中, 具有高发病率、高致残率、高死亡率等特点, 且治疗后表现出较高复发率, 预后效果相对较差<citation id="111" type="reference"><link href="86" rel="bibliography" /><sup>[<a class="sup">5</a>]</sup></citation>。目前, 临床上主要通过溶栓、扩容、抗血小板聚集、改善脑代谢等方法治疗脑梗死伴颈动脉粥样斑块患者, 但总效果欠佳, 且治疗后不良事件发生率相对较高, 较难取得良好预后。单独给予脑梗死伴颈动脉粥样斑块患者者辛伐他汀治疗, 可使患者血脂水平、临床症状得到有效改善, 但改善效果仍需提高。本研究在常规对症处理基础上给予该类患者辛伐他汀和脑蛋白水解物治疗, 在血液流变学改善、CRP水平降低、LVEF提高等几个方面均取得较理想效果, 总体疗效较显著。</p>
                </div>
                <div class="p1">
                    <p id="60">血液黏度升高、红细胞聚集增加, 导致血液流速减缓, 形成血栓, 进而导致脑梗死、心肌梗死发生。有报道指出, 血液流变学相关指标异常是脑梗死发生的一个重要征兆, 且与脑梗死严重程度、范围存在密切关系<citation id="112" type="reference"><link href="88" rel="bibliography" /><sup>[<a class="sup">6</a>]</sup></citation>。因此, 降低血黏度对脑梗死治疗、预防效果的提高均具有重要意义。研究中所用脑蛋白水解物为一种具有典型性的神经保护剂, 其目前已被广泛应用于血管性痴呆、脑卒中、新生儿缺氧缺血性脑病等疾病临床治疗中, 并取得良好效果<citation id="113" type="reference"><link href="90" rel="bibliography" /><sup>[<a class="sup">7</a>]</sup></citation>。有研究结果表明, 脑蛋白水解物应用过程中可直接通过血脑屏障, 对呼吸链功能、神经细胞核酸代谢、蛋白质合成产生影响, 进而使脑组织代谢、功能得到有效改善<citation id="114" type="reference"><link href="92" rel="bibliography" /><sup>[<a class="sup">8</a>]</sup></citation>。本研究将脑蛋白水解物、辛伐他汀应用于联合治疗组患者临床治疗中后, 该组患者HCT从 (49.85±4.92) %下降至 (37.72±2.41) %, PA从 (57.89±10.28) %下降至 (38.10±2.52) %, FBG从 (4.91±1.58) g/L下降至 (3.18±1.15) %, WBV从 (5.63±0.57) mPa·s下降至 (1.55±0.25) mPa·s, PV从 (1.63±0.36) mPa·s下降至 (1.21±0.16) mPa·s, LVEF从治疗前 (45.18±2.41) %提高至 (56.67±4.37) , 该组后各项血液流变学指标均显著低于常规治疗组, 组间差异对比有统计学意义。由此可知, 脑蛋白水解物应用于脑梗死伴颈动脉粥样斑块患者临床治疗, 可使患者血液流变学、左心室射血分数得到有效改善, 其作用机制主要如下:①含有诸多种多肽、氨基酸, 可促进缺氧状态下脑组织产生腺苷三磷酸, 使脑组织所需能量得到补充;②可促进离子泵能量增加, 降低氧自由基生成;③对大脑中兴奋性、抑制性物质平衡状态产生调节, 加快神经细胞修复速度;④提高脑细胞对氧的利用, 促进脑细胞损伤得到有效缓解, 使脑组织功能得到更大程度恢复。CRP可对人血管内皮细胞产生直接致炎效应, CRP水平升高可直接作为引发血管内皮功能失调的一个独立因素<citation id="115" type="reference"><link href="94" rel="bibliography" /><sup>[<a class="sup">9</a>]</sup></citation>。通过对动脉斑块周围发生的炎性反应进行抑制, 并增强斑块周围存在血管内皮细胞稳定性, 能够有效延缓斑块变大速度, 降低卒中及相关心脑血管事件的发生风险<citation id="116" type="reference"><link href="86" rel="bibliography" /><sup>[<a class="sup">5</a>]</sup></citation>。目前, 诸多临床研究结果均已证实, 他汀类药的应用除了发挥良好降脂作用外, 还可对血管内炎性反应有效抑制, 且该类药物毒副作用相对较小, 长时间服用通常不会引发严重不良反应<citation id="117" type="reference"><link href="96" rel="bibliography" /><sup>[<a class="sup">10</a>]</sup></citation>。</p>
                </div>
                <div class="p1">
                    <p id="61">辛伐他汀作为临床应用较为普遍的一种他汀类药物, 将其应用于脑梗死伴颈动脉粥样斑块患者临床治疗中, 可使斑块构成发生改变, 进而使巨噬细胞增殖有效降低, 对氧化应激产生抑制作用, 使血管内皮稳定性显著提高, 进而可减少血栓生成, 可使颈动脉斑块发生逆转<citation id="118" type="reference"><link href="98" rel="bibliography" /><sup>[<a class="sup">11</a>]</sup></citation>。本研究将辛伐他汀应用于联合治疗组患者治疗后, 该组患者CRP水平从治疗前 (5.79±1.09) mg/L降低至 (1.70±0.20) mg/L, 且下降程度显著大于常规治疗组。此外, 他汀类药物的应用还表现出良好心脏保护作用。李小华<citation id="119" type="reference"><link href="100" rel="bibliography" /><sup>[<a class="sup">12</a>]</sup></citation>等及Xu X<citation id="120" type="reference"><link href="102" rel="bibliography" /><sup>[<a class="sup">13</a>]</sup></citation>等研究均已经明确他汀类药物存在多向性效应, 其在应用过程中可对细胞迁移、增生等产生有效抑制, 促进脑梗死患者颈动脉堵塞、狭窄得到快速解除, 进而解决心肌血流再灌注问题, 提高LVEF。脑蛋白水解物与辛伐他汀联合应用可大大提高抗炎、改善血液流变学等效果。</p>
                </div>
                <div class="p1">
                    <p id="62">研究中给予联合治疗组患者脑蛋白水解物和辛伐他汀治疗后, 该组CRP水平有显著下降, LVEF显著升高, 相关血液流变学指标也均得到良好改善, 且各项观察指标的改善程度均大于常规治疗组。该结果表明, 两种药物应用于该类患者治疗中, 可有效减缓脑组织周围炎症反应, 改善患者脑部血流状况, 保护神经系统<citation id="121" type="reference"><link href="104" rel="bibliography" /><sup>[<a class="sup">14</a>]</sup></citation>。治疗后, 患者NIHSS评分可显著减少、颈动脉斑块面积缩小程度更大, 获得更高治疗总有效率, 且可降低心脑血管事件发生率。由此可知, 给予脑梗死伴颈动脉粥样斑块患者辛伐他汀联合脑蛋白水解物治疗可获得更理想总体疗效。总之, 与常规治疗手段相比, 将辛伐他汀、脑蛋白水解物用于脑梗死伴颈动脉粥样斑块患者治疗, 可使有效降低CRP水平, 提升左心室射血分数, 进而获得更理想总体疗效, 因此该种治疗方案值得在临床上推广应用。</p>
                </div>

        <!--brief end-->
        
        <!--conten left  end-->
        <!--增强附件-->
        

        <!--reference start-->
            <div class="reference anchor-tag" id="a_bibliography">
                    <h3>参考文献</h3>
                                        <p id="78">
                            <a id="bibliography_1" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGYZ201301017&amp;v=MDU0NjZHNEg5TE1ybzlFWTRRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbFZML01QeXJTZEw=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[1]</b>陈先震, 沈照立, 薛飞, 等.葛根素辅助脑蛋白水解物治疗缺血性脑血管病预后疗效分析J].中国医院药学杂志, 2013, 33 (1) :49-52.
                            </a>
                        </p>
                        <p id="80">
                            <a id="bibliography_2" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GLYZ201603001&amp;v=MTk3OTdML01JaUhTZExHNEg5Zk1ySTlGWllRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbFY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[2]</b>宋爱霞, 纪蓉, 刘俊峰, 等.脑梗死患者血清生物标志物水平与颈动脉斑块的相关性研究[J].中国临床药理学杂志, 2016, 32 (3) :195-197, 201.
                            </a>
                        </p>
                        <p id="82">
                            <a id="bibliography_3" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=LCSJ201501019&amp;v=MDkxMTlNS1M3WVpMRzRIOVRNcm85RWJZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWTC8=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[3]</b>谢坚, 张虹桥, 章成国, 等.瑞舒伐他汀与阿托伐他汀对急性脑梗死患者血脂、血清超敏C反应蛋白及颈动脉粥样硬化斑块作用的比较[J].临床神经病学杂志, 2015, 28 (1) :37-41.
                            </a>
                        </p>
                        <p id="84">
                            <a id="bibliography_4" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJESDDB5D60B4D17B6B1858F9DD6B53E5778&amp;v=MTU2NzdtQXdlc2VSUXIyWENPTnZGU2lXV3I3SklGcG1hQnVIWWZPR1FsZkJyTFUwNXRCaHhMaTR3S3c9TmlmT2ZjZk1iTlM0cVk4M1lKOE9DdzQvdlJjYjd6Y0xRUXVXcQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[4]</b>Chen R, Xiao A, Ma L, et al.Elevated hemoglobin is associated with cerebral infarction in Tibetan patients with primary hemorrhagic neurovascular diseases[J].Clin Neurol Neurosurg, 2017, 12 (16) :46-50.
                            </a>
                        </p>
                        <p id="86">
                            <a id="bibliography_5" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GAYX201317049&amp;v=MDU0NzFOcUk5QmJZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWTC9NSWl6U2RyRzRIOUw=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[5]</b>钟楚锋, 黎丽娴, 周环, 等.醒脑静联合脑蛋白水解物对脑卒中患者血管内皮依赖性舒张功能的影响[J].广东医学, 2013, 34 (17) :2713-2714.
                            </a>
                        </p>
                        <p id="88">
                            <a id="bibliography_6" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZFSJ201602003&amp;v=MjgzNDFIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbFZML01QeXZZWkxHNEg5Zk1yWTlGWjRRS0Q=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[6]</b>李强, 华梅, 李鸣, 等.强化他汀治疗对脑梗死患者血清HMGB1 IL-17A和S-100A12水平的影响[J].中风与神经疾病杂志, 2016, 33 (2) :109-112.
                            </a>
                        </p>
                        <p id="90">
                            <a id="bibliography_7" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWD&amp;filename=SJWD5CF0A631DB8BB6B403753D295D23FDAE&amp;v=MDI5MjlMVTA1dEJoeExpNHdLdz1OaWZjYXJiTGFORzlxWXhFRUprSGZnNC92UklUNlRoNFN3dmdwUmRCZTdIaU1jdnFDT052RlNpV1dyN0pJRnBtYUJ1SFlmT0dRbGZCcg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[7]</b>Yokokawa R, Akino H, Ito H, et al.Nerve growth factor release from the urothelium increases via activation of bladder C-fiber in rats with cerebral infarction[J].Neurourol Urodyn, 2017, 36 (6) :1448-1455.
                            </a>
                        </p>
                        <p id="92">
                            <a id="bibliography_8" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZLXZ201619039&amp;v=MDQzOTlLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpsVkwvTVB5SFRkTEc0SDlmTnBvOUdiWVE=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[8]</b>张成刚, 孙中武.阿托伐他汀钙联合氯吡格雷预防老年短暂性脑缺血发作患者脑梗死的效果及对血脂、血小板的影响[J].中国老年学杂志, 2016, 36 (19) :4759-4760.
                            </a>
                        </p>
                        <p id="94">
                            <a id="bibliography_9" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XDYF201306006&amp;v=MTA2NDR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbFZML01QU25TYUxHNEg5TE1xWTlGWW9RS0RIODQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[9]</b>张慧敏.C反应蛋白水平与脑梗死患者颈动脉粥样硬化的相关性研究[J].现代预防医学, 2013, 40 (6) :1011-1012, 1016.
                            </a>
                        </p>
                        <p id="96">
                            <a id="bibliography_10" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGYA201726031&amp;v=Mjc0NTA1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbFZML01QeXJTYjdHNEg5Yk9xWTlHWllRS0RIODR2UjRUNmo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[10]</b>王映林, 李青叶.辛伐他汀对脑梗死患者神经功能及预后的影响[J].中国药房, 2017, 28 (26) :3708-3710.
                            </a>
                        </p>
                        <p id="98">
                            <a id="bibliography_11" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZSJJ201411001&amp;v=MTE5NjFIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbFZML01QejdCWkxHNEg5WE5ybzlGWllRS0Q=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[11]</b>岳蕴华, 白旭东, 张小宁, 等.普罗布考联合阿托伐他汀对脑梗死患者血清hsCRP、ox-LDL、MMP-9水平及颈动脉斑块的影响[J].中国神经精神疾病杂志, 2014, 40 (11) :641-645.
                            </a>
                        </p>
                        <p id="100">
                            <a id="bibliography_12" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZLXZ201522052&amp;v=MDQxMjRSN3FmWnVabUZ5amxWTC9NUHlIVGRMRzRIOVRPclk5QVpvUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1U=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[12]</b>李小华, 黄康.瑞舒伐他汀与辛伐他汀治疗老年冠心病伴高胆固醇血症的临床对比[J].中国老年学杂志, 2015, 35 (22) :6427-6428.
                            </a>
                        </p>
                        <p id="102">
                            <a id="bibliography_13" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJESF9879F87B77AF0D2074EE26221B2C134&amp;v=MjI3MTk0d0t3PU5pZk9mY1d4RnRiRjJZZENGdXdJZlFvNXV4UVQ3VHNJUFgza3JoQTBDN0RuUkxtYkNPTnZGU2lXV3I3SklGcG1hQnVIWWZPR1FsZkJyTFUwNXRCaHhMaQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[13]</b>Xu X, Li C, Wan T, et al.Risk Factors for Hemorrhagic Transformation After Intravenous Thrombolysis in Acute Cerebral Infarction:A Retrospective Single-Center Study[J].World Neurosurg, 2017, 101:155-160.
                            </a>
                        </p>
                        <p id="104">
                            <a id="bibliography_14" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201103021&amp;v=MTAwMTlNUFRYTVpiRzRIOURNckk5SFpZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWTC8=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[14]</b>张安兴.不同剂量阿托伐他汀钙预防颈动脉粥样硬化患者脑梗塞的作用[J].心血管康复医学杂志, 2011, 20 (3) :256-257.
                            </a>
                        </p>
            </div>
        <!--reference end-->
        <!--footnote start-->
        <!--footnote end-->



    </div>

        <input id="fileid" type="hidden" value="XXGK201903024" />
        <input id="dpi" type="hidden" value="200" />
    </div>

<script>
var _hmt = _hmt || [];
(function() {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?6e967eb120601ea41b9d312166416aa6";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();
</script>

    


<input id="hid_uid" name="hid_uid" type="hidden" value="WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
<input id="hid_kLogin_headerUrl" name="hid_kLogin_headerUrl" type="hidden" value="/KLogin/Request/GetKHeader.ashx%3Fcallback%3D%3F" />
<input id="hid_kLogin_footerUrl" name="hid_kLogin_footerUrl" type="hidden" value="/KLogin/Request/GetKFooter.ashx%3Fcallback%3D%3F" />
<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201903024&amp;v=MDIzMTA1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbFZML05QVFhNWmJHNEg5ak1ySTlIWUlRS0RIODR2UjRUNmo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>
<div class="popflow" id="popupTips" style="display: none;">
    <div class="popflowArr"></div>
    <div class="popflowCot">
        <div class="hd"><a href="javascript:void(0);" onclick="$('#popupTips').hide();$('#popupmsg').html('')" class="close">X</a></div>
        <div class="bd">
            <p class="mes" id="popupmsg" name="popupmsg"></p>
          
        </div>
    </div>
</div>
<input type="hidden" id="myexport" value="//kns.cnki.net" />

<input type="hidden" id="KPCAPIPATH" value="//ishufang.cnki.net" />
<input type="hidden" id="CitedTimes" value="" />
<div class="link" id="GLSearch" style="display: none;">
    <i class="icon-trangle"></i>
    <div class="inner">
        <a class="icon" id="copytext">复制</a>
        <a class="icon" target="_blank" onclick="searchCRFD(this)">工具书搜索</a>
    </div>
</div>




<input id="hidVirtualPath" name="hidVirtualPath" type="hidden" value="/kxreader" />
<script src="/kxreader/bundles/detail?v=842_VlRz_g1CMCLi-M0twVw-4EOFG_noWyi_OsMnrAg1"></script>

<script src="/kxreader/Scripts/layer.min.js" type="text/javascript"></script>

<div id="footerBox" class="rootw footer">
</div>
<script>
    if (typeof FlushLogin == 'function') {
        FlushLogin();
    }
    modifyEcpHeader(true);
</script>

<!--图片放大功能 start-->
<script src="/kxreader/bundles/imagebox?v=W4phPu9SNkGcuPeJclikuVE3PpRyIW_gnfjm_19nynI1"></script>

<script type="text/javascript">
    $(function () {
        var j = $.noConflict();
        j(function () {
            j(".zoom-in,.btn-zoomin").imgbox({
                'alignment': 'center',
                'allowMultiple': false,
                'overlayShow': true
            });
        })
    });
</script>
<!--图片放大功能 end-->
<div class="fixedbar">
    <div class="backtop hiddenV" id="backtop">
        <a id="backTopSide" href="javascript:scroll(0,0);" title=""></a>
    </div>
</div>
<script type="text/javascript" src="/kxreader/Scripts/MathJax-2.6-latest/MathJax.js?config=MML_HTMLorMML-full"></script>

</body>
</html>
